This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arena Pharmaceuticals Inc (ARNA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 163.21M 221.88M 156.09M 57.63M
Receivables 3.71M 10.60M 5.56M 607.00K
Inventories 10.83M 12.76M 6.06M 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 181.90M 248.81M 171.16M 60.26M
Property, Plant & Equipment, Gross 174.94M 165.37M 159.33M 157.33M
Accumulated Depreciation & Depletion 92.02M 87.98M 83.92M 75.26M
Property, Plant & Equipment, Net 82.92M 77.39M 75.42M 82.07M
Intangibles 8.48M 10.18M 10.61M 11.03M
Other Non-Current Assets 3.09M 3.43M 4.02M 3.77M
Total Non-Current Assets 94.49M 91.00M 90.05M 96.87M
Liabilities & Shareholder Equity
Total Assets 276.38M 339.81M 261.21M 157.13M
Accounts Payable 34.77M 23.03M 3.88M 2.36M
Short Term Debt 2.49M 2.06M 1.66M 1.31M
Other Current Liabilities 474.00K 567.00K 3.07M 0.00
Total Current Liabilities 67.36M 70.74M 29.91M 14.36M
Long Term Debt 0.00 0.00 0.00 14.70M
Deferred Income Taxes 369.00K 247.00K 122.00K 0.00
Other Non-Current Liabilities 93.06M 106.22M 59.74M 43.05M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 161.68M 177.21M 132.65M 132.21M
Total Liabilities 229.04M 247.95M 162.57M 146.57M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 47.34M 91.86M 98.64M 10.56M
Common Par 22.00K 22.00K 22.00K 15.00K
Additional Paid In Capital 1.31B 1.29B 1.28B 1.11B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.27B -1.21B -1.19B -1.08B
Treasury Stock 0.00 0.00 0.00 -23.07M
Other Equity Adjustments 2.91M 5.73M 5.49M 4.74M
Total Capitalization 47.34M 91.86M 98.64M 25.26M
Total Equity 47.34M 91.86M 98.64M 10.56M
Total Liabilities & Stock Equity 276.38M 339.81M 261.21M 157.13M
Total Common Shares Outstanding 220.32M 218.82M 217.48M 146.09M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 3.00M
Basic Weighted Shares Outstanding 219.73M 218.10M 196.52M 139.17M
Diluted Weighted Shares Outstanding 219.73M 218.10M 196.52M 139.17M
Number of Employees 325 310 293 266
Number of Part-Time Employees 0 0 0 0

ARNA Arena Pharmaceuticals Inc

Chart of ARNA

Analysts Ratings for ARNA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

ARNA Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs